Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium deep neuromuscular blockade in laparoscopic cholecystectomy
IRCT20220519054914N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of rocuronium (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Intra-abdominal pressure and Quality of surgical conditions. Started Sep 2022; status: completed.
02
Drugs
rocuronium
Beyond the preview
Go deeper on IRCT20220519054914N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220519054914N1.